ELEVAI is healing in a bottle

Using innovative stem cell technology, the ELEVAI Post Treatment E-Series product line captures the bodies’ natural repair response. Powered by ethically sourced, human umbilical mesenchymal stem cells (hUMSC)-derived exosomes, the ELEVAI Post Treatment E-Series promotes youthful rejuvenation for deeply healthier skin.

ELEVAI empower is proven to support healing post ablative procedures in office. From chemical peels to micro needling, lasers and post surgical applications.

ELEVAI enfinity is created as a stable, daily take home product for your clients. Enfinity combines the power of hUMSC derived exosomes with the best synergistic anti ageing ingredients available today.

Our Team

Our co-founders already have the expertise, experience and networks
to successfully sell in this space

Dr. Jordan R. Plews

Co-Founder & Chief Executive Officer

Jordan R. Plews, PhD, is Cofounder & Chief Executive Officer of ELEVAI Skincare. He has had leading roles in building teams, consulting, and advising on clinical development programs and product launches at various pharmaceutical companies including Pfizer, where he led the bioprocess development group and worked on skin cancer treatments and biologics.


Dr. Plews, whose research has been published in top tier medical journals such as Nature Methods and the Journal of Cellular and Molecular Medicine, obtained his postdoctoral training at Stanford University. There, he conducted research and trained Ph.D. students. Following many years of research utilizing various types of stem cells to treat a variety of health issues, Dr. Plews co-founded Xytogen Biotech in 2015, a California based cosmeceutical company developing next-generation topical, stem cell based skincare solutions. Over a five-year period, he led a team to build a fully-functioning stem cell culture laboratory, and launched over five high-end products that generated multi-million dollars in top line national sales.

Dr. Plews’ career spans biochemical engineering, molecular biology, and stem cell applications. He earned a Ph.D. from and received first class honors in the engineering doctorate program in Biochemical Engineering & Bioprocess Management at University College London.

Dr. Tim Sayed

Co-Founder & Chief Medical Officer

Tim Sayed, MD, MBA, FACS is Cofounder and Chief Medical Officer of ELEVAI Skincare. Dr. Sayed is a double board-certified plastic surgeon with nearly two decades of experience who practices in Southern California. Presently, he owns and operates plastic surgery offices in Southern California and draws patients from all around the United States and world.


Dr. Sayed has served as a medical director and investor at electronic health records and practice management company Modernizing Medicine, with over $300M in financing raised, including Warburg Pincus Series F. He has also served as vice president and seed investor at Interpreta, which provides precision medicine clinical interpretation solutions. Dr. Sayed has also served on the board of Fruit Street Health, which has raised over $15M from physician investors and has customer relationships with ShareCare and Walgreens. Dr. Sayed also serves on the advisory board of Featherlink, a company which applies artificial intelligence to help improve surgical outcomes. He also is on the advisory board at Seqster, a software-based platform to manage comprehensive electronic medical records, which has received strategic funding from Takeda.

Dr. Sayed oversees product development, marketing and brings academic knowledge and clinical experience in aesthetics, anti-aging, skincare, and health technology. Dr. Sayed completed medical training at UCSF and surgical residency at Harvard Medical School. He holds a B.S. in electrical engineering and computer sciences from Berkeley, M.D. from UCSF School of Medicine, and M.B.A. from the Kellogg School of Management at Northwestern University.